How cost-effective fermentation enables synthetic biology beyond pharmaceuticals
Synthetic biology first gained prominence through its impact on pharmaceuticals, where engineered microbes produce insulin, vaccines, and complex biologic drugs. Over the past decade, the same core capabilities—precise genetic design, scalable fermentation, and data-driven optimization—have matured and become cost-effective enough to address challenges far beyond medicine. As a result, synthetic biology is now expanding rapidly into materials science, targeting sectors such as textiles, construction, packaging, and electronics.This expansion stems from the alignment of advanced technology, rising sustainability demand, and the inherent constraints of conventional material production.Technologies Driving the Widespread GrowthSeveral technical advances have lowered the barriers to applying synthetic biology…
